# Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age

> **NCT07348692** · PHASE3 · RECRUITING · sponsor: **Sanofi** · enrollment: 2195 (estimated)

## Conditions studied

- Pneumococcal Immunization
- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** PCV21 vaccine
- **BIOLOGICAL:** 20vPCV licensed vaccine

## Key facts

- **NCT ID:** NCT07348692
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-20
- **Primary completion:** 2027-06-07
- **Final completion:** 2028-05-29
- **Target enrollment:** 2195 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07348692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07348692, "Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07348692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*